Busy. Please wait.

show password
Forgot Password?

Don't have an account?  Sign up 

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
Don't know
remaining cards
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

list of drugs-unit 1

all drugs for neuropharm final

Reserpine -inhibits VMAT -> depletes vesicular stores of monoamines (DA, NE, 5-HT) -decreases hypertension -15% of people taking reserpine for hypertension developed depressive-like symptoms - Parkinsonian side effects
L-DOPA -Patients with Parkinson’s were given L-DOPA (a version of the dopamine precursor DOPA) to enhance DA transmission -Many patients obtained relief from EPS, but some developed an acute, positive-sx psychosis as a treatment side effect.
AMPT -(α‐methyl‐p-tyrosine)competes for tyrosine binding site; no clinical use -blocks catecholamine synthesis by blocking Tyrosine Hydroxylase
SKF 38393 -D1R agonist: stimulates locomoter activity (i.e. grooming) -no clinical use
SCH23390 -D1R antagonist -no clinical use
Haloperidol -D2R antagonist: used to treat schizophrenia (classic antipsychotic) -Treats POSITIVE symptoms of schizophrenia with little effect on negative or cognitive symptoms -decreases reinforcing properties of cocaine but also impairs locomotion
Amphetamine -blocks DAT/NET, releases DA/NE b/c reversal of VMAT -used to treat ADHD: Amphetamine + dextroamphetamine (Adderall™)
Cocaine ?
Methylphenidate -blocks DAT and to a lesser extent NET -used to treat ADD= Ritalin -Abuse liability of methylphenidate is not related to DAT occupancy or peak plasma levels of methylphenidate, but appears to be related to the magnitude of the increase in DA/unit time
Atomoxetine -blocks NET, non stimulant -increases DA/NE in FC, not striatum, b/c more DAT in striatum -used to treat ADD
Clonidine -alpha2-adrenergic agonist that stimulates autoreceptors and inhibits noradrenergic cell firing. -used to reduce hypertension and opiate withdrawal -side effects: sedation, feelings of sleepiness
Vesamicol -drug that blocks the vesicular ACh transporter
HC-3 (hemicholinium-3) -drug that blocks the choline transporter in cholinergic nerve terminal (inhibits choline reuptake)
Physostigmine -blocks AChE activity -Eserine -symptoms include slurred speech, mental confusion, hallucinations, loss of reflexes, convulsions, coma, and death -isolated from Calabar beans
Muscarine -alkaloid that stimulates muscarinic cholinergic receptors that are selectively stimulated by muscarine
Scopolamine -drug that blocks muscarinic receptors -found in night shade and henbane -causes cognitive impairments, delirium, and tachycardia (hallucinogen)
p‐chlorophenylalanine (PCPA) -drug that irreversibly inhibits tryptophan hydroxylase, blocking 5-HT synthesis
p‐chloroamphetamine (PCA) Drug similar in structure to amphetamine that stimulates 5-HT release. It is also neurotoxic at high doses
8‐OH‐DPAT agonist at 5-HT1A receptor can cause: hyperphagia(autoreceptors), hypothermia, anxiolytic
Buspirone -agonist at 5-HT1A receptor -symptoms include increased appetite,reduced axiety, reduced alcohol cravings, and a lower body temp. -prescribed as an antianxiety medication
WAY100635 -drug that selectively inhibits 5-HT1A receptors
Fluoxetine (Prozac) -selectively blocks the 5-HT transporter -clinical use: antidepressant
Ketanserin -nonselective 5-HT2A receptor antagonists -used to decrease hypertension
allylglycine -blocks GABA synthesis -causes convulsions
picrotoxin -noncompetitive antagonist at GABA(A) receptor -causes convulsions
Benzodiazepine -class of drugs that act as CNS depressants through positive allosteric modulation of GABA(A) receptor activity -prescribed as anti-anxiety meds: -high abuse liability -intense side effects:sedative/hypnotic effects, muscle relaxant, anti-convulsant
Diazepam and Chlordiazepoxide -Benzodiazepines -used clinically in detox to minimize alcohol withdrawal symptoms
Barbiturate (class of drug) -positive allosteric modulators;increase mean open time of GABA(A) channel • Have similar effects as BDZs
muscimol -classic GABA(A) receptor agonist -Causes macroscopia,hyperthermia, pupil dilation,increased mood, difficulties concentrating, anorexia, ataxia, hallucinations
bicuculline -competitive antagonist at GABA(A) receptor -causes seizures
Baclofen (Lioresal) -selective agonist for the GABA(B) receptor -used as muscle relaxant and anti-spastic agent
NBQX -antagonist that blocks both AMPA and kainate receptors but has no effect on NMDA receptors
phencyclidine (PCP) -binds to the PCP site and acts as noncompetitive antagonist of the NMDA receptor -dissociative anesthetic that was once used medicinally but now is only taken recreationally
Ketamine -drug that binds to PCP site and acts as noncompetitive antagonist at NMDA receptor -dissociative anesthetic used in both human and veterinary medicine, and it is also used recreationally
Created by: 4304716